...
首页> 外文期刊>Cancer science. >Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis.
【24h】

Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis.

机译:在人T细胞白血病病毒1型相关淋巴结病变中CC趋化因子配体18的上调和CX3C趋化因子受体1的表达下调:趋化因子和趋化因子受体DNA芯片分析的结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Adult T-cell leukemia/lymphoma (ATLL) is a human malignancy associated with human T-cell leukemia virus type 1 (HTLV-1). The pathological features of the lymph nodes of ATLL change from those of lymphadenitis to Hodgkin's-like features and those of lymphoma. Chemokines and their receptors are closely associated with T-cell subgroups and immune responses. To clarify the relationship between chemokines and their receptor expression, as well as the development of ATLL, 17 cases with ATLL were analyzed using DNA chips of chemokines and their receptors. All cases showed a varied and mixed pattern of upregulated and downregulated gene expression of Th1, Th2, naive, and cytotoxic cell-associated chemokine genes. As CC chemokine ligand 18 (CCL18) accounted for the most upregulated gene and CX3C chemokine receptor 1 (CX3CR1) for the most downregulated gene, they were selected for immunohistochemical analysis. Immunohistochemical staining showed expression of the two genes in immunological cells, with a positiveexpression for reticulum cells, but not for ATLL cells. HTLV-1-associated lymphadenitis type (n = 13) and Hodgkin's-like type (n = 12) cases showed significantly higher CCL18 expression than the non-specific lymphadenitis cases (n = 10) (P < 0.05). However, all HTLV-1-associated cases showed significantly lower CX3CR1 expression than the non-specific lymphadenitis cases (P < 0.05). These results suggest that upregulation of CCL18 expression and downregulation of CX3CR1 expression play a role in immune responses against the ATLL cells.
机译:成人T细胞白血病/淋巴瘤(ATLL)是与1型人类T细胞白血病病毒(HTLV-1)相关的人类恶性肿瘤。 ATLL淋巴结的病理特征从淋巴结炎的病理特征变为霍奇金样特征以及淋巴瘤的病理特征。趋化因子及其受体与T细胞亚群和免疫反应密切相关。为了阐明趋化因子与其受体表达以及ATLL的发展之间的关系,使用趋化因子及其受体的DNA芯片分析了17例ATLL患者。所有病例均显示Th1,Th2,幼稚和细胞毒性细胞相关趋化因子基因上调和下调基因表达的变化和混合模式。由于CC趋化因子配体18(CCL18)占上调最多的基因,而CX3C趋化因子受体1(CX3CR1)占下调最多的基因,因此选择它们进行免疫组化分析。免疫组织化学染色显示这两个基因在免疫细胞中表达,对网状细胞为阳性表达,而对ATLL细胞则不表达。 HTLV-1相关淋巴结炎型(n = 13)和霍奇金样类型(n = 12)病例的CCL18表达明显高于非特异性淋巴结炎病例(n = 10)(P <0.05)。但是,所有与HTLV-1相关的病例均比非特异性淋巴结炎病例的CX3CR1表达明显降低(P <0.05)。这些结果表明CCL18表达的上调和CX3CR1表达的下调在针对ATLL细胞的免疫反应中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号